Shaobo Xue
Impact in
- Rehabilitation top 5%
- Wound Healing and Treatments
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Ubiquitin and proteasome pathways 3
- RNA modifications and cancer 3
- Circular RNAs in diseases 2
- Histone Deacetylase Inhibitors Research 2
- Oncology 6
- Co-authors
- Han Lin (3 shared papers)Zunzhen Ming (3 shared papers)Meiyu Bao (3 shared papers)Huanhuan Zhu (2 shared papers)Sujing Qiang (3 shared papers)Weiwei Liu (1 shared paper)Da Fu (6 shared papers)Yu‐Shui Ma (6 shared papers)
- Journals
- Molecular Therapy — Oncolytics (2 papers)Advanced Science (2 papers)Cell Death Discovery (1 paper)Advanced Healthcare Materials (1 paper)Molecular Cancer (1 paper)
- Partner nations
- China
In The Last Decade
Shaobo Xue
20 papers receiving 705 citations
Shaobo Xue's Hit Papers
Peers
Comparison fields: 5 of 87
- Rehabilitation 123
- Cancer Research 118
- Biomaterials 109
- Molecular Medicine 32
- Pharmaceutical Science 25
Countries citing papers authored by Shaobo Xue
This map shows the geographic impact of Shaobo Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaobo Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaobo Xue more than expected).
Fields of papers citing papers by Shaobo Xue
This network shows the impact of papers produced by Shaobo Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaobo Xue. The network helps show where Shaobo Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Shaobo Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Living Bacterial Hydrogels for Accelerated Infected Wound Healing Hit paper breakdown → | 2021 | 245 |
| 2 | 2014 | 67 | |
| 3 | 2018 | 67 | |
| 4 | 2020 | 60 | |
| 5 | 2015 | 51 | |
| 6 | 2018 | 41 | |
| 7 | 2018 | 36 | |
| 8 | 2020 | 27 | |
| 9 | 2019 | 20 | |
| 10 | 2024 | 15 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 11 | |
| 13 | 2024 | 11 | |
| 14 | 2020 | 11 | |
| 15 | 2021 | 9 | |
| 16 | 2020 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2024 | 5 | |
| 20 | 2025 | 1 |
About Shaobo Xue
Shaobo Xue is a scholar working on Molecular Biology, Oncology, Cancer Research, Biomedical Engineering and Epidemiology, having authored 21 papers that have together received 712 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Ubiquitin and proteasome pathways (3 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Antimicrobial Peptides and Activities (2 papers), Circular RNAs in diseases (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Rehabilitation (123 citations), Cancer Research (118 citations), Biomaterials (109 citations), Molecular Medicine (32 citations) and Pharmaceutical Science (25 citations). Shaobo Xue has collaborated with scholars based in China. Frequent co-authors include Han Lin, Zunzhen Ming, Meiyu Bao, Huanhuan Zhu, Sujing Qiang, Weiwei Liu, Da Fu, Yu‐Shui Ma, Gai‐Xia Lu and Guangpeng Liu. Their work appears in journals such as Molecular Therapy — Oncolytics, Advanced Science, Cell Death Discovery, Advanced Healthcare Materials and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.